These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 7917775)
1. Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin. Chan E; McLachlan AJ; Pegg M; MacKay AD; Cole RB; Rowland M Br J Clin Pharmacol; 1994 Jun; 37(6):563-9. PubMed ID: 7917775 [TBL] [Abstract][Full Text] [Related]
2. Determination of unbound warfarin enantiomers in human plasma and 7-hydroxywarfarin in human urine by chiral stationary-phase liquid chromatography with ultraviolet or fluorescence and on-line circular dichroism detection. Takahashi H; Kashima T; Kimura S; Muramoto N; Nakahata H; Kubo S; Shimoyama Y; Kajiwara M; Echizen H J Chromatogr B Biomed Sci Appl; 1997 Nov; 701(1):71-80. PubMed ID: 9389340 [TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of warfarin metabolism by diltiazem in humans. Abernethy DR; Kaminsky LS; Dickinson TH J Pharmacol Exp Ther; 1991 Apr; 257(1):411-5. PubMed ID: 2020000 [TBL] [Abstract][Full Text] [Related]
4. Disposition of drugs in cystic fibrosis. VI. In vivo activity of cytochrome P450 isoforms involved in the metabolism of (R)-warfarin (including P450 3A4) is not enhanced in cystic fibrosis. Wang JP; Unadkat JD; McNamara S; O'Sullivan TA; Smith AL; Trager WF; Ramsey B Clin Pharmacol Ther; 1994 May; 55(5):528-34. PubMed ID: 8181197 [TBL] [Abstract][Full Text] [Related]
5. The disposition of the enantiomers of warfarin following chronic administration to rats: relationship to anticoagulant response. Pratt SK; Winn MJ; Park BK J Pharm Pharmacol; 1989 Nov; 41(11):743-6. PubMed ID: 2576040 [TBL] [Abstract][Full Text] [Related]
6. The mechanism of the warfarin-rifampin drug interaction in humans. Heimark LD; Gibaldi M; Trager WF; O'Reilly RA; Goulart DA Clin Pharmacol Ther; 1987 Oct; 42(4):388-94. PubMed ID: 3665337 [TBL] [Abstract][Full Text] [Related]
7. Warfarin metabolites: stereochemical aspects of protein binding and displacement by phenylbutazone. Chan E; McLachlan AJ; Rowland M Chirality; 1993; 5(8):610-5. PubMed ID: 8305289 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of warfarin and 7-hydroxywarfarin enantiomers by high-performance liquid chromatography with ultraviolet detection. Miura M; Okuyama S; Kato S; Kagaya H; Murata A; Komatsuda A; Wakui H; Sawada K Ther Drug Monit; 2011 Feb; 33(1):108-14. PubMed ID: 21157402 [TBL] [Abstract][Full Text] [Related]
9. Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone. Takahashi H; Sato T; Shimoyama Y; Shioda N; Shimizu T; Kubo S; Tamura N; Tainaka H; Yasumori T; Echizen H Clin Pharmacol Ther; 1999 Dec; 66(6):569-81. PubMed ID: 10613612 [TBL] [Abstract][Full Text] [Related]
10. Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes. Takahashi H; Kashima T; Nomizo Y; Muramoto N; Shimizu T; Nasu K; Kubota T; Kimura S; Echizen H Clin Pharmacol Ther; 1998 May; 63(5):519-28. PubMed ID: 9630825 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of warfarin enantiomers and its metabolite in human plasma by column-switching high-performance liquid chromatography with chiral separation. Uno T; Niioka T; Hayakari M; Sugawara K; Tateishi T Ther Drug Monit; 2007 Jun; 29(3):333-9. PubMed ID: 17529891 [TBL] [Abstract][Full Text] [Related]
12. Stereospecific fluorescence high-performance liquid chromatographic analysis of warfarin and its metabolites in plasma and urine. Banfield C; Rowland M J Pharm Sci; 1984 Oct; 73(10):1392-6. PubMed ID: 6502487 [TBL] [Abstract][Full Text] [Related]
13. The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study. Gemmati D; Burini F; Talarico A; Fabbri M; Bertocco C; Vigliano M; Moratelli S; Cuneo A; Serino ML; Avato FM; Tisato V; Gaudio RM PLoS One; 2016; 11(9):e0162084. PubMed ID: 27606428 [TBL] [Abstract][Full Text] [Related]
14. The mechanism of the interaction between amiodarone and warfarin in humans. Heimark LD; Wienkers L; Kunze K; Gibaldi M; Eddy AC; Trager WF; O'Reilly RA; Goulart DA Clin Pharmacol Ther; 1992 Apr; 51(4):398-407. PubMed ID: 1563209 [TBL] [Abstract][Full Text] [Related]
15. Steady-state clearance rates of warfarin and its enantiomers in therapeutically dosed patients. McAleer SD; Foondun AS; Feely M; Chrystyn H Chirality; 1997; 9(1):13-6. PubMed ID: 9094197 [TBL] [Abstract][Full Text] [Related]
16. Effects of folic acid supplementation on the pharmacokinetics and anticoagulant effect of warfarin: an open-label, prospective study of long-term administration in adults. Muszkat M; Bialer O; Blotnick S; Adar L; Xie HG; Ufer M; Cascorbi I; Caraco Y Clin Ther; 2010 Feb; 32(2):347-56. PubMed ID: 20206792 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: application of In vitro approaches to predicting In vivo reduction of (S)-warfarin clearance. Takahashi H; Kashima T; Kimura S; Murata N; Takaba T; Iwade K; Abe T; Tainaka H; Yasumori T; Echizen aH Drug Metab Dispos; 1999 Oct; 27(10):1179-86. PubMed ID: 10497145 [TBL] [Abstract][Full Text] [Related]
18. Combination index of the concentration and in vivo antagonism activity of racemic warfarin and its metabolites to assess individual drug responses. Kobayashi S; Ishii K; Yamada Y; Ryu E; Hashizume J; Nose S; Hara T; Nakashima M; Ohyama K J Thromb Thrombolysis; 2019 Apr; 47(3):467-472. PubMed ID: 30465164 [TBL] [Abstract][Full Text] [Related]
19. Stereoselective disposition of flurbiprofen in uraemic patients. Knadler MP; Brater DC; Hall SD Br J Clin Pharmacol; 1992 Apr; 33(4):377-83. PubMed ID: 1576066 [TBL] [Abstract][Full Text] [Related]
20. Simultaneous measurement of S-warfarin, R-warfarin, S-7-hydroxywarfarin and R-7-hydroxywarfarin in human plasma by liquid chromatography-tandem mass spectrometry. Zuo Z; Wo SK; Lo CM; Zhou L; Cheng G; You JH J Pharm Biomed Anal; 2010 Jun; 52(2):305-10. PubMed ID: 20133101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]